- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
SEDANA
STO
Week ended 07 Aug 2026
Weekly Investor Report
Sedana Medical AB (publ) · Healthcare · Medical Devices
Latest close
10.68 SEK
9.0%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 13.7% above the Trend Line and sits at 25.7% of its 52-week range. The latest completed week returned 9.0%, after a 19.6% four-week move. The latest news-sentiment score is 50/100.
Setup score
42
out of 100
Latest Close
10.68 SEK
7 Aug 2026
1W Return
9.0%
latest completed week
4W Return
19.6%
short-term follow-through
12W Return
9.3%
quarterly tape
Trend Breadth
13.5%
7 of 52 weeks active
Volume Ratio
2.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 43.99% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
9.0%
Latest completed week; four-week move 19.6%.
Indicator stack
7/67
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.99%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
27 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 13.7% above the Trend Line and sits at 25.7% of its 52-week range. The latest completed week returned 9.0%, after a 19.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1112-week average 0.13
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.11Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 19.6% over four weeks, 9.3% over 12 weeks, and -32.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year7
Trend breadth13.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.22Latest activity-pressure read.
Pressure change168.3%Four-week change in activity pressure.
Leadership-9.71Latest relative-leadership reading.
RS change62.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 27 relevant articles.
2 positive · 23 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-41.7%Distance below the 52-week high.
13-week volatility5.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2611 weeks finished lower.
Best week+13.0%Week of 31 Jul.
Worst week-8.0%Week of 27 Feb.
Latest week+9.0%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains7
Flat weeks1
Modest losses4
Sharp losses7
Recent vol5.4%13-week weekly-return volatility.
Base vol5.5%52-week weekly-return volatility.
Up/down split25/26Count of positive and negative weeks in the 52-week window.
Average skew3.9% / -5.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank5 / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Medical Devices
4-week rank2 / 46
Group average-3.1%
Trend breadth23.9%
Trend23.9%active weekly trend signals
MD41.3%positive activity pressure
RS10.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape32/100
Trend, activity pressure, participation, and risk combine to a 32/100 tape read.
Indicator analysis21/100Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 0/12.
Activity pressure 0.11; No reversal markers Next-Week ExpectancyNegative 43.99%Next-week expectancy is negative with a 43.99% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 27 relevant articles.
Sedana Medical AB Revenue Breakdown – MUN:7D2A Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 10.68 SEK | 9.0% | 9.39 SEK | 15.46 SEK | 0.22 | -9.71 | 561.5K | Off |
| 31 Jul 2026 | 9.80 SEK | 13.0% | 9.37 SEK | 15.53 SEK | -0.10 | -16.75 | 552.9K | Off |
| 24 Jul 2026 | 8.67 SEK | 0.3% | 9.40 SEK | 15.61 SEK | -0.40 | -26.46 | 293.6K | Off |
| 17 Jul 2026 | 8.64 SEK | -3.2% | 9.44 SEK | 15.71 SEK | -0.35 | -26.87 | 239.8K | Off |
| 10 Jul 2026 | 8.93 SEK | 2.6% | 9.50 SEK | 15.82 SEK | -0.32 | -26.09 | 153.8K | Off |
| 3 Jul 2026 | 8.70 SEK | 4.8% | 9.55 SEK | 15.89 SEK | -0.39 | -30.07 | 22.6K | Off |
| 26 Jun 2026 | 8.30 SEK | 2.2% | 9.60 SEK | 16.00 SEK | -0.20 | -32.00 | 31.3K | Off |
| 19 Jun 2026 | 8.12 SEK | -6.3% | 9.66 SEK | 16.12 SEK | 0.08 | -34.56 | 639.1K | Off |
| 12 Jun 2026 | 8.67 SEK | -4.2% | 9.70 SEK | 16.25 SEK | 0.40 | -29.22 | 82.5K | Off |
| 5 Jun 2026 | 9.05 SEK | -3.8% | 9.73 SEK | 16.38 SEK | 0.62 | -26.72 | 80.2K | Off |
| 29 May 2026 | 9.41 SEK | -4.5% | 9.76 SEK | 16.53 SEK | 0.67 | -25.03 | 276.9K | Off |
| 22 May 2026 | 9.85 SEK | 0.8% | 9.79 SEK | 16.66 SEK | 0.76 | -22.40 | 505.0K | Off |
| 15 May 2026 | 9.77 SEK | -0.2% | 9.82 SEK | 16.77 SEK | 0.72 | -20.95 | 218.6K | Off |
| 8 May 2026 | 9.79 SEK | -5.1% | 9.92 SEK | 16.87 SEK | 0.65 | -22.47 | 380.7K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.